CellSource Co., Ltd. (JP:4880) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CellSource Co., Ltd. has announced the acquisition of Medibase Co., Ltd., a provider of cloud-based EMRs tailored for cosmetic surgery and dermatology, aiming to enhance operational efficiency and performance of medical institutions. The integration seeks to leverage synergies in beauty-related medical practices, with an expectation of contributing to CellSource’s medium to long-term performance improvement. The impact on current fiscal performance is anticipated to be minor.
For further insights into JP:4880 stock, check out TipRanks’ Stock Analysis page.